Recent research presented at the 2025 Society of Thoracic Surgeons (STS) Annual Meeting has shed light on the survival benefits of anatomic lung resections, specifically lobectomy and segmentectomy, for patients diagnosed with stage 1A non-small cell lung cancer (NSCLC). Utilizing data from the STS
Clinical trials are the backbone of medical advancements, but they face a persistent challenge: participant adherence. Non-adherence can skew results, impact outcomes, and undermine the effectiveness of health solutions. Enter digital adherence tools, which are revolutionizing the landscape by
The transformative potential of AI-powered self-triage tools in healthcare is becoming increasingly evident. Imagine a world where smartphones act as the frontline against illness, capable of assessing symptoms, offering personalized advice, and guiding patients to appropriate care with
Imagine a world where antibiotics are so precisely targeted that they only attack harmful bacteria, leaving beneficial microorganisms unharmed and reducing the risk of antibiotic resistance. This scenario may not be as far-fetched as it seems, thanks to the pioneering work of researchers at the
The intricate relationship between socioeconomic development and the global cancer burden is a critical area of study that warrants thorough exploration. Utilizing data from the GLOBOCAN 2020 report, this article delves into the disparities in cancer incidence, mortality, and healthcare outcomes
Stanford Medicine researchers have recently introduced an innovative artificial intelligence (AI) model named MUSK (multimodal transformer with unified mask modeling) that significantly improves the accuracy of cancer prognosis predictions. By integrating both visual and textual medical data, this
